BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang Y, Yusoff NM, Du J, Moses EJ, Lin JT. Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease. World J Stem Cells 2024; 16(7): 760-772 [PMID: 39086561 DOI: 10.4252/wjsc.v16.i7.760]
URL: https://www.wjgnet.com/1948-0210/full/v16/i7/760.htm
Number Citing Articles
1
Fei-Qiong Gao, Jia-Qi Zhu, Xu-Dong Feng. Innovative mesenchymal stem cell treatments for fatty liver diseaseWorld Journal of Stem Cells 2024; 16(9): 846-853 doi: 10.4252/wjsc.v16.i9.846
2
Bobae Kim, Rwubuzizi Ronaldo, Beet-Na Kweon, Solhee Yoon, Yein Park, Jea-Hyun Baek, Jung Min Lee, Chang-Kee Hyun. Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin AxisInternational Journal of Molecular Sciences 2024; 25(19): 10447 doi: 10.3390/ijms251910447
3
Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Mesenchymal stem cells: A promising therapeutic avenue for non-alcoholic fatty liver diseaseWorld Journal of Stem Cells 2024; 16(8): 780-783 doi: 10.4252/wjsc.v16.i8.780
4
Yu-Xin Jin, Hang-Qi Hu, Jia-Cheng Zhang, Xi-Yan Xin, Yu-Tian Zhu, Yang Ye, Dong Li. Mechanism of mesenchymal stem cells in liver regeneration: Insights and future directionsWorld Journal of Stem Cells 2024; 16(9): 842-845 doi: 10.4252/wjsc.v16.i9.842
5
Xiao-Qian Shan, Lan Zhao. Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease?World Journal of Stem Cells 2024; 16(10): 854-859 doi: 10.4252/wjsc.v16.i10.854